Inflammatory bowel disease and thromboembolism.

Area of Science:

• Gastroenterology
• Vascular Medicine
• Hematology

Background:

• Inflammatory bowel disease (IBD) is associated with a significantly increased risk of vascular complications, including both venous and arterial thromboembolism.
• These thromboembolic events are serious extraintestinal manifestations that contribute to morbidity and mortality in IBD patients.
• IBD itself is recognized as an independent risk factor for developing thromboembolic disease.

Purpose of the Study:

• To review the epidemiology and clinical presentation of thromboembolic complications in patients with IBD.
• To elucidate the underlying pathophysiology connecting IBD and thrombosis.
• To discuss current strategies for preventing and managing thromboembolic disease in the IBD population.

Main Methods:

• This is a review article, synthesizing existing literature on IBD and thromboembolism.
• The review focuses on epidemiological data, clinical features, and pathogenetic mechanisms.
• Management and prevention strategies are discussed based on current evidence.

Main Results:

• Thromboembolic complications are a frequent and serious concern in IBD patients.
• The etiology is multifactorial, involving interactions between acquired and inherited factors affecting both local intestinal and systemic circulation.
• Thrombosis appears to be a specific feature integral to IBD pathogenesis and event occurrence.

Conclusions:

• Increased awareness and prompt diagnosis/management of thromboembolic complications are crucial for IBD patient care.
• Understanding the complex interplay of factors contributing to thrombosis in IBD is essential for effective prevention.
• Further research into the precise mechanisms is needed to optimize therapeutic strategies for thromboembolism in IBD.